Lin Sun
Department of Nephrology, Second Xiangya hospital of central south university, Changsha, China. · Affiliated Hospital of Jining Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lin Sun as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:50 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07359027 · Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney DiseaseSecond Xiangya Hospital of Central South University · completed · Diabetic Kidney Disease, Anemia · principal investigator
- N/ANCT03805191 · A Study for Sufficient Acarbose Decreased Glucose Excursion in Type 2 Diabetic PatientsQilu Hospital of Shandong University · unknown · Type 2 Diabetes Mellitus, Poor Glycemic Control · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 7 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:50 UTC. The ranking covers the 200 most relevant of 782 PubMed records, and a shared surname and initials can bring in a namesake. All 782 on PubMed
- An inactivated enterovirus 71 vaccine in healthy children.N Engl J Med · 2014329 citationsRCR 12.0
- Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.J Exp Med · 2021267 citationsRCR 11.9
- Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy.N Engl J Med · 2025239 citationsRCR 48.2
- 233 citationsRCR 19.9
- Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.JAMA Oncol · 2020202 citationsRCR 9.1
- Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.Lancet Oncol · 2013191 citationsRCR 4.7
- Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study.Signal Transduct Target Ther · 2023156 citationsRCR 12.7
- 131 citationsRCR 16.3
- 116 citationsRCR 6.6
- Fuzheng Jiedu Xiaoji formulation inhibits hepatocellular carcinoma progression in patients by targeting the AKT/CyclinD1/p21/p27 pathway.Phytomedicine · 2021100 citationsRCR 6.9